MYO7A p.Ala2083Thr
c.6247G>A · rs41298759 · VCV178496
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1032 | likely benign |
|---|---|---|
| REVEL | 0.276 | benign-leaning |
| SaProt | LLR -5.51 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · G>T here scores Δ0.34 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 8.7 | GERP 0.55, phastCons 1 |
| Regional constraint | o/e 0.95 | unconstrained · MANE · 84 kb · p 0.0065 · regional, not allelic |
| Overall | ||
| CADD | 23.4 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.142% | 705 |
| South Asiangrpmax | 0.13% | 772 |
| Remaining individualsnot grpmax-eligible | 0.0528% | 1,893 |
| European (non-Finnish) | 0.0406% | 2,463 |
| Middle Eastern | 0.0165% | 6,062 |
| Admixed American | 0.0133% | 7,502 |
| Finnishnot grpmax-eligible | 0.00938% | 10,664 |
| African / African-American | 0.00933% | 10,718 |
| East Asian | 0.00223% | 44,866 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- MYO7A
- Protein
- p.Ala2083Thr
- Coding
- c.6247G>A
- MANE Select
- NM_000260
- dbSNP
- rs41298759
- Type
- single nucleotide variant
- Location
- chr11:77211830 (GRCh38)
- Gene constraint
- LOEUF 0.995 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 77.73 · 1 PDB
- Residue 2083
- the ferm 2 domain; an α-helix
Disease context
Inborn genetic diseases — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: hearing loss disorderMeniere diseaseUsher syndrome type 1autosomal recessive nonsyndromic hearing loss 2autosomal dominant nonsyndromic hearing loss 11Usher syndrome type 1B
Similar variants
- MYO7A p.Ala2083Val Uncertain significance ★ ⚠ same residue
- MYO7A p.Ala2083fs Likely pathogenic ★ same residue
- MYO7A p.Ala2083= Likely benign ★ same residue
- MYO7A p.Ala1288Pro Likely pathogenic ★★★ same condition
- MYO7A p.Arg1168Gln Pathogenic ★★★ ⚠ same condition
- MYO7A p.Arg1873Gln Pathogenic ★★★ ⚠ same condition
- MYO7A p.Arg395Cys Likely pathogenic ★★★ ⚠ same condition
- MYO7A p.Arg668Cys Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/myo7a-p-ala2083thr (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown